 Altamira Therapeutics Ltd NASDAQ: CYTO announced topline data from its clinical trial with Bentrio nasal spray in house dust mite HDM allergic rhinitis. The HDM challenge trial demonstrated a statistically significant reduction of nasal symptoms vs. 